Overview
Pharmalucence, Inc., purchased by Sun Pharma on July 15, 2014, has held a long-standing position in the manufacture and marketing of Radiopharmaceuticals. Now, as part of the larger Sun company, Pharmalucence will no longer seek contract manufacturing projects from third parties as it begins to serve as Sun’s primary domestic injectable manufacturing facility.
Pharmalucence is nearing completion of its new fully automated and isolated aseptic drug production facility. This new facility will offer best in class compliance and performance.